| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |